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Abstract
Introduction: HIV in Vietnam and Southern China is driven by injection drug use. We have implemented HIV prevention
interventions for IDUs since 2002–2003 in Lang Son and Ha Giang Provinces, Vietnam and Ning Ming County (Guangxi),
China.
Methods: Interventions provide peer education and needle/syringe distribution. Evaluation employed serial cross-sectional
surveys of IDUs 26 waves from 2002 to 2011, including interviews and HIV testing. Outcomes were HIV risk behaviors, HIV
prevalence and incidence. HIV incidence estimation used two methods: 1) among new injectors from prevalence data; and
2) a capture enzyme immunoassay (BED testing) on all HIV+ samples.
Results: We found significant declines in drug-related risk behaviors and sharp reductions in HIV prevalence among IDUs
(Lang Son from 46% to 23% [p,0.001], Ning Ming: from 17% to 11% [p = 0.003], and Ha Giang: from 51% to 18% [p,0.001]),
reductions not experienced in other provinces without such interventions. There were significant declines in HIV incidence
to low levels among new injectors through 36–48 months, then some rebound, particularly in Ning Ming, but BED-based
estimates revealed significant reductions in incidence through 96 months.
Discussion: This is one of the longest studies of HIV prevention among IDUs in Asia. The rebound in incidence among new
injectors may reflect sexual transmission. BED-based estimates may overstate incidence (because of false-recent results in
patients with long-term infection or on ARV treatment) but adjustment for false-recent results and survey responses on
duration of infection generally confirm BED-based incidence trends. Combined trends from the two estimation methods
show sharp declines in incidence to low levels. The significant downward trends in all primary outcome measures indicate
that the Cross-Border interventions played an important role in bringing HIV epidemics among IDUs under control. The
Cross-Border project offers a model of HIV prevention for IDUs that should be considered for large-scale replication.
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Almost 150 countries on all continents had reported injection
drug use by 2007 and 120 of these had reported related HIV
infections. HIV prevalence among the 16 million injection drug
users (IDUs) worldwide is estimated at 19% [1]. Injection drug use
is driving HIV epidemics in many countries in Asia, the Middle
East, and Eastern Europe [1]. This is true in southern China and
all of Vietnam. Controlling the HIV/AIDS epidemics in these
countries depends on controlling HIV among IDUs [2].
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There are more than 200,000 IDUs in Vietnam (representing
about 0.7% of the male population aged 15–65), with an overall
HIV prevalence of 30% (as high as 56% in some provinces);
approximately 60% of all reported HIV cases have been among
IDUs [3] (National Institute of Hygiene and Epidemiology and
FHI360, unpublished data, 2009). In China, there are between 1.8
and 3 million IDUs (0.4%–0.6% of the male population aged 15–
64), with national HIV prevalence estimated at 8%–19% [1].
Prevalence is higher than 50% in several provinces and about 32%
of HIV infections are attributed to injection drug use [4].
The effectiveness of interventions for controlling HIV epidemics
among IDUs –peer outreach, needle/syringe provision programs
(NSP) and opioid substitution treatment (OST) – is supported by
many research studies [5]. Epidemic modeling has shown that
combination prevention composed of NSP, OST, and antiretro-
viral treatment will significantly reduce HIV incidence among
IDUs [6,7].
There have been NSPs in both China and Vietnam since the
late 1990s. In China, small pilots gave way to a larger government-
funded program with more than 1,000 sites across the country,
although coverage remains quite low [8]. In Vietnam, there were
also a few pilots in the late 1990s and some expansion of NSP since
then, but these programs are still predominantly funded by
international donors. The government has not yet assumed
responsibility for scaling up NSP in Vietnam. While the
Vietnamese and Chinese governments have supported harm
reduction interventions, both countries still maintain important
elements of a ‘‘social evils’’ approach toward drug use, which has
resulted in large-scale arrest and commitment of IDUs to drug
detention centers [9–13].
To counter the argument that confinement of drug users is the
best way to contain HIV, further evidence of the effectiveness of
community-based harm reduction such as NSP and OST is
needed. There have been only a few other evaluations of NSP in
Vietnam and China and these relied on quite limited data [14–
15]. This paper presents a long-term evaluation of the Cross-
Border HIV Prevention Project for IDUs in Southern China and
Northern Vietnam. It is based on analysis of perhaps the longest
data series on HIV among IDUs in Asia, assembled from cross-
sectional surveys of IDUs carried out between 2002 and 2011 [16–
19]. We focus here on trends in primary outcomes: HIV risk
behaviors, HIV prevalence, and HIV incidence.
The idea for the Cross-Border Project originated at a training
session on HIV prevention for IDUs in Kunming, China in 1997.
During that meeting, two co-authors of the present paper (T.H.,
D.D.J.) discussed with counterparts from China and Vietnam the
possibility of developing a harm reduction intervention for IDUs
in a China-Vietnam border region experiencing linked epidemics
of heroin injection and HIV infection. After more than four years
of work to negotiate the necessary partnerships and to assemble
the required funding, the Cross-Border Project’s interventions for
IDUs were launched in Ning Ming County (Guangxi), China in
June, 2002 and in Lang Son Province, Vietnam in September,




The Cross-Border Project was the first HIV prevention project
for IDUs in which the same interventions were implemented on
both sides of an international border, in this case the border
between northern Vietnam and southern China. Beginning in the
early to middle 1990s, this area experienced epidemics of heroin
injection and subsequently HIV infection among IDUs. As shown
by Beyrer et al. [20], an important heroin trans-shipment route
ran from the Golden Triangle of Laos, Thailand, and Burma into
Northern Vietnam and thence into Southern China and to Hong
Kong and the larger world. As heroin was shipped through the
border region, drug users shifted from traditional opium smoking
to heroin smoking and then quite quickly, for reasons of cost-
effectiveness, to heroin injection. A map of the Cross-Border
Project sites is presented in Figure 1.
As we have shown in an earlier paper, there was a gradient of
HIV prevalence in the Cross-Border sites from the highest in the
localities in Vietnam farthest from the China border to the lowest
in the Chinese sites farthest from the Vietnam border [21]. While
other patterns of HIV transmission may also have occurred, this
prevalence gradient suggests that the dual epidemics of heroin
injection and HIV infection moved from south to north through
the border area. We also showed that border crossing behavior
was associated with being HIV-infected among IDUS from both
Chinese and Vietnamese sites [22].
The Cross-Border interventions are based on a ‘‘peer outreach’’
model developed in the U.S. in the late 1980s [23–26]. This model
was implemented from the beginning of the project in 2002 in
Lang Son Province, Vietnam and Ning Ming County, China. In
Ha Giang Town between 2003 and 2005, a ‘‘peer-driven
intervention’’ (PDI) was implemented. This model, which essen-
tially applies Respondent-Driven Sampling to delivery of HIV
prevention messages and commodities, involves large numbers of
IDUs as recruiters and deliverers of harm reduction services in
return for small rewards [27], as opposed to the peer outreach
model, which employs regular peer educators who receive
monthly stipends for their work. In 2005, the PDI in Ha Giang
Town was converted to a peer outreach model because we
concluded that it had already reached all of the IDUs – indeed, the
PDI reached 900 IDUs, far more than the 700 estimated by the
health department to live in Ha Giang.
In the peer outreach model, initial groups of peer educators
(PEs) were recruited by local health departments based on
performance during initial training, recommendations from IDU
‘‘gatekeepers’’, and expressed interest in joining the project. The
original intention was that the peer educators be former IDUs.
However, it quickly became apparent that very few IDUs in these
sites had been able to stop injecting heroin. Therefore, it was
necessary to recruit primarily current IDUs. Most of the PEs are
young men but women PEs have been recruited to reach women
IDUs as well as sexual partners of IDUs and sex workers in
companion interventions for women at risk.
The initial groups of PEs received two weeks of training and the
local health departments have provided periodic refresher
training. In addition, the peer educators’ weekly meetings include
training on special topics. The peer educators are supervised
locally by health department staff. Because there were different
funding sources and local cost norms, PEs’ stipends differed across
sites: from $30 per month in Lang Son to $46 in Ha Giang to $117
in Ning Ming.
For a variety of reasons, mostly associated with the peer
educators’ ongoing drug use, commitment to drug detention
centers, arrest for petty crimes, or moving away, there has been
substantial turnover among them. Turnover rates varied by year
and by site but sometimes reached 50% per year. Local health
department staff recruit and train replacements as needed.
The peer educators regularly contact other IDUs in the
community and provide them with information on reducing drug
use- and sex-related HIV risks, verbally and through distribution
of brochures. They distribute new needles/syringes, ampoules of
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sterile water for injection solution, and condoms and vouchers
redeemable for these items at participating pharmacies. The peer
educators also perform a valuable public health service by
collecting and disposing of used needles/syringes that might
otherwise put community residents at risk.
The average annual cost of these interventions was $60,000–
$75,000 per province (that is, all sites in the province), including
the cross-sectional surveys. (More detailed information on the
interventions may be found in a replication manual available from
the corresponding author [28]).
The interventions aim to reduce HIV risk behaviors among
IDUs, thereby stabilizing HIV prevalence and reducing HIV
incidence on both sides of the border and preventing cross-border
HIV transmission. We consider this a structural intervention
because it seeks not only to influence the behavior of individual
IDUs (e.g., reduction or elimination of the sharing of injection
equipment) but also to diffuse HIV risk reduction messages and
sterile injection equipment more widely through the IDU
community [29–30].
The Cross-Border interventions have reached substantial
proportions of the IDUs in the project sites through direct contact
with PEs and ‘‘secondary exchange’’ in which IDUs receiving
needles/syringes directly from the project pass on some of these to
other IDUs. Through this and other means, the HIV risk
reduction information and safer injection materials disseminated
by the project are also reaching IDUs who do not personally
interact with the project.
The cross-border project also seeks to diffuse knowledge of HIV
and build support for the interventions in the general community.
Project staff have regular meetings with police, local government
bodies (e.g., People’s Committees), Communist Party officials, and
mass organizations (e.g., Women’s Union, Youth Union). Staff
and peer educators also regularly attend community meetings.
These interactions build and maintain support for the interven-
tions. Government leaders in Ning Ming, Lang Son, and Ha
Giang gave initial approval to the interventions and directed all
departments, including the police, as well as the general
community, to give their support and cooperation. This support
has been maintained but it requires constant nurturing through
regular meetings and other interactions. Peer educators and
project staff must repeatedly explain that the purpose of the
project is to prevent disease and not to encourage drug use or give
special treatment to drug users. Misinformation and misunder-
standing are seemingly endemic, and the peer educators and
project staff must constantly work to prevent misinformation and
misunderstanding from undermining the interventions [28].
Overall Evaluation Design
The evaluation of structural interventions poses complex
methodological challenges. We believe that our interventions are
appropriately evaluated at the community level rather than the
individual level. Randomized controlled trials of these interven-
tions pose serious ethical and cost issues.
Our design relies primarily on serial cross-sectional surveys of
IDUs (including behavioral interviews and HIV testing) just before
the start of the interventions and at follow up intervals thereafter.
All survey waves reported on in this paper were carried out in the
same sites in Ning Ming County, China (Ning Ming City, Aidian,
Figure 1. Map of Cross-Border Project sites.
doi:10.1371/journal.pone.0043141.g001
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Shilang, and Tongmian) and Lang Son (Lang Son City, Cao Loc,
Loc Binh, Hop Thanh, Dong Dang, and Tan Thanh) and Ha
Giang Provinces (Ha Giang Town), Vietnam. Data collection
methods were largely parallel in Ning Ming County, Lang Son
and Ha Giang, with some variation in the strategies used to recruit
IDUs for the surveys. Routine monitoring data were employed to
gauge levels of activities and commodities provided.
Subject Recruitment
To be eligible, survey participants had to be at least 18 years of
age and to have injected heroin in the past 6 months. In all sites,
modified ‘‘snowball’’ techniques were used. These involved
identification of initial respondents through project PEs, lists of
registered IDUs, and/or IDUs present at mapped ‘‘shooting’’
places or other gathering places, with the remainder of sample
quotas from each site recruited through snowball or chain referral
methods. Chinese participants received 20 yuan (approximately
$2.50) for the interview and blood sample, 5 yuan for each
additional male respondent recruited, and 10 yuan for each
additional woman respondent recruited. Vietnamese participants
received 30,000 dong (about US$1.50) for the interview and blood
sample.
Informed Consent
An interviewer explained the survey procedures to each
prospective participant. In Vietnam, a verbal informed consent
was obtained from participants, with the interviewer certifying that
consent by signing the form. This procedure was recommended by
the Institutional Review Board of the National AIDS Standing
Bureau in order to provide more assurance of confidentiality to
prospective participants. In China, a standard signed informed
consent was obtained from each participant.
Unique ID codes were constructed for each IDU participant
composed of several letters and numbers representing, for
example, the first letter of the mother’s family name and the
subject’s date of birth. The objective was to have a unique
identifier composed of items that participants could readily
reconstruct in order to obtain their HIV test results. Test results
were coded only by these identifiers.
Questionnaire
A structured instrument was used for the interviews, based on
version 2b of the questionnaire employed in the World Health
Organization’s Drug Injection Study, Phase II [31]. The
questionnaire includes a series of demographic and self-reported
behavioral items. Most of the behavioral questions pertain to
specific drug-related and sexual activities and measures of
participation in the intervention during the 6-month period prior
to the interview. (The full questionnaire is available upon request
from the corresponding author.).
The interviews were conducted by trained staff of the local
health departments. The baseline IDU survey in Lang Son
Province, Vietnam was conducted in January, 2002 with 7
subsequent waves between March, 2003 and October, 2009. The
36-month and 60-month surveys had to be skipped because of
temporary gaps in funding. In Ha Giang Town, Vietnam the
baseline survey took place in January, 2003 with 9 additional
waves between August, 2003 and February, 2011. The baseline
survey in Ning Ming County, China occurred in July-August,
2002 with 7 subsequent waves between April, 2003 and June,
2008. Thus, in total we have data from 26 cross-sectional survey
waves among IDUs across all sites.
HIV Testing
The surveys included HIV antibody testing. Participants were
given pre- and post-test counseling at local health centers. Blood
was drawn by trained phlebotomists at the time of the interviews.
Participants were told to return to the local health center on a
certain date to receive their test results using their ID numbers.
In China, testing was by double ELISA (Vironostika HIV-uni-
form, Organon [Holland]) with confirmation of initial HIV-
positive results by Western blot methodology (Genelabs Diagnos-
tics). All testing was conducted at the laboratory of the Guangxi
Center for HIV/AIDS Prevention and Control in Nanning. In
Vietnam, testing was performed at the laboratory of the Lang Son
and Ha Giang Provincial Health Services using the Serodia SFD
screening test (Biorad [France]) and double ELISA (Genescreen,
Biorad [France]; Vironostika, Organon [Holland]). This is the
official protocol of the Vietnam Ministry of Health.
BED Testing
To identify recent infections and inform HIV incidence
estimates, we conducted BED capture-enzyme immunoassay
testing [32–34] on HIV-positive serum/plasma samples using
the Calypte HIV-1 BED EIA (Calypte Biomedical Corporation,
Rockville, MD) for all Ning Ming samples, Lang Son 48-, 72-,
and 84-month surveys, and Ha Giang 60-, 72- and 96-month
surveys. The BED assay measures the proportion of IgG that is
anti-HIV antibody and uses a multi-subtype synthetic peptide
antigen for detection of HIV-1 subtypes B, E, and D. For Ning
Ming, frozen HIV-positive serum/plasma samples were avail-
able from all survey waves and BED testing was carried out by
the laboratory of the Guangxi CDC in Nanning, China. For the
Vietnamese sites, we had frozen HIV-positive serum/plasma
samples only from three survey waves (48, 72, and 84 months)
in Lang Son and from three survey waves (60, 72, and 96
months in Ha Giang Town). This was because samples from
earlier waves were not frozen. BED testing of Vietnamese
samples, except for those from the Ha Giang 96-month survey,
was done at the Thai Ministry of Public Health-U.S. Centers
for Disease Control and Prevention HIV/STI Laboratory in
Nonthaburi, Thailand. BED testing for Ha Giang’s 96-month
survey was done at the National Institute of Hygiene and
Epidemiology in Hanoi.
Ethical Review
The study was reviewed and approved by the institutional
review boards (IRBs) of the following institutions: Guangxi Center
for HIV/AIDS Prevention and Control, the National AIDS
Standing Bureau of Vietnam, Lang Son and Ha Giang Provincial
Health Services, Abt Associates Inc., and Beth Israel Medical
Center, New York, NY. The BED testing of Vietnamese samples
in Thailand was done under a non-research determination from
CDC.
Analysis
Data sets were prepared in EpiInfo, version 6.04 by staff of the
Guangxi Center for HIV/AIDS Prevention and Control (for Ning
Ming) and, over time in Vietnam by staff of the National AIDS
Standing Bureau and Abt Associates. The data were analyzed at
Abt Associates Inc. using SAS, Version 9.22 (SAS, Inc., Cary,
NC). For all analyses, we considered a measure to be statistically
significant if it had an estimated p-value of less than or equal to
0.05.
Cross-Border HIV Prevention in Vietnam and China
PLOS ONE | www.plosone.org 4 August 2012 | Volume 7 | Issue 8 | e43141
Trends in HIV Risk Behaviors and HIV Prevalence
To analyze trends in risk behaviors and HIV prevalence, we
used regression analysis to estimate a time trend for each behavior
and HIV prevalence. Separate regressions were run for each
project site. Tests of significance for trends used a linear time
trend, adding covariates for specific geographic subunits. We also
took into account the potential correlation generated by multiple
responses from the same respondents over time, using a robust
covariance matrix with clustering on the survey respondent. The
robust covariance matrix will not affect the estimated parameters
from a model assuming independent and identically distributed
errors, but will change the estimated parameter covariance matrix
[35]. To estimate the model for these outcomes, we used the SAS
SURVEYLOGISTIC procedure and the CLUSTER command
to cluster the error matrix on survey respondents [36]. The model
assumes clustering among responses from the same participant but
independence across survey participants.
Comparative Analysis of HIV Prevalence Trends
To explore further the possible associations between the
interventions and trends in HIV prevalence, we compared the
trends in our Vietnam project sites to those from sentinel
surveillance in other northern Vietnam provinces without similar
interventions (Dien Bien, Lao Cai, Bac Giang, Cao Bang, and Phu
Tho) and compared the trends in Ning Ming to those in Yunnan
Province, China, which also lacked similar interventions during
the period under study. For these comparisons, we used a
difference-in-difference estimator [37] to calculate the trend in
HIV prevalence within project sites and ‘‘difference out’’ the
underlying trend in HIV prevalence occurring in comparison
provinces.
Ha Giang began its intervention in 2003, while Lang Son began
in 2002. In Dien Bien, sentinel surveillance data were available for
2004 forward. In Lao Cai, sentinel surveillance reported HIV
prevalence at 3 to 6 percent in 2000 through 2003, but not less
than 14 percent in subsequent years (18 to 22 percent in 2004
through 2006). The rise in HIV prevalence seems suspicious
between 2003 and 2004, so we elected to use data from 2004 to
2009 for the Vietnam comparisons. Changing the time period
would not substantially change the results. To determine the trend
in the Vietnamese comparison sites, we used a weighted least-
squares regression, with the weights equaling 1 divided by the
square root of the number of tests in each site for each year (for
details, see Model Specifications S1). The dependent variable was
the proportion testing positive for that site in that year.
Independent variables included dummy variables for each site,
and a time trend for each site (equaling 0 in 2004 and 1 in 2009).
To compute the change in prevalence across the five provinces, we
used a simple average of the percent decline in prevalence over the
time period 2004 to 2009.
We used similar estimation techniques for China to compare
HIV prevalence trends among IDUs in Ning Ming with those in
Yunnan Province for the period 2002–2007, based on data in a
paper by Jia [38]. We estimated a weighted least-squares
regression, with the weights equaling 1 divided by the square root
of the number of tests for each year. The dependent variable was
the proportion testing positive in that year. The independent
variable was a time trend (equaling 0 in 2002 and 1 in 2007). In
the comparison with Yunnan Province, we also added a time-
squared trend to the model because it greatly improved model fit
(for details, see Model Specifications S1).
In both countries, we ran similar regressions for our project
sites. For each project site, we ran separate regressions that
included dummy variables for the subsite (in Lang Son and Ning
Ming), demographic variables that included marital status, ethnic
minority status, age (dummy variable for 21–30), indicator for
male, and a time trend. For each site, we ran a linear probability
model. In China, we used a generalized estimating equation with
repeated measures for each person. For Vietnam, we used an OLS
regression.
Trends in HIV Incidence
We employed two methods to estimate trends in HIV incidence:
analysis of new injectors and BED testing. As described elsewhere
[16], we estimated HIV incidence among new injectors, defined as
individuals reporting injection histories of three years or less. To
test the significance of a trend in estimated HIV incidence, we
used a Generalized Estimating Equation [39] with a normal
distribution and an identity link [35]. We estimated the GEE using
the GENMOD procedure in SAS. In the GEE, the incidence was
the dependent variable, the project site and survey wave were
independent variables, and we allowed clustering when an
individual appeared in more than one survey. The test of
significance was based upon the z-statistic reported for the survey
wave.
Our second method was based on BED testing, which can
identify recent infections (approximately within the past six
months) from samples that are HIV-positive on antibody tests
[32–34]. BED results can be used to estimate HIV incidence from
cross-sectional data [40].
Annual HIV incidence (I) was estimated based on the BED test
results using the formula in the Calypte kit insert (I = ([365/w]
Ninc)/(Nneg + [365/w] Ninc/2) where w, is the window or recency
period, Ninc is the number of recent infections and Nneg is the
number of HIV negatives in a survey wave. Using BED data from
190 seroconversion panels from Thailand [41], we determined the
recency period (the mean period from initial seroconversion to an
ODn of 0.8) as 152 days.
When specimens from all HIV-positives were not available for
BED testing, the BED estimate was extrapolated by the factor: (#
BED-recent/# of HIV-positive specimens available for testing).
This assumes that the proportion of specimens that test positive for
recent infection is the same as in those with available and missing
specimens. Many of the calculated incidence rates were very close
to or below zero. As a result, we computed confidence intervals
based upon the Wilson score interval [42].
Adjustments to BED-based incidence estimates are advised
because of the possibility of the test producing false-recent results.
We selected the adjustment proposed by Welte [43]. This method
adjusts well for variance in recency periods, among other factors
proposed by McDougal [44] and Hargrove [45]. Such adjustments
to very low incidence rates may generate negative values.
In addition to applying this adjustment, we examined survey
responses for all participants with BED-recent results (linked
through study ID numbers) on whether and when these
individuals had been told that they had HIV infection and
duration of any ARV treatment. Where linkage between names
and study numbers was still available, we were able to check
putative ‘‘recent’’ infections against registries of outpatient clinics
providing ARV treatment. Any cases of long-term infection or
ARV treatment initiated more than 6 months before the survey
were excluded as recent infections for HIV incidence estimation.
Results
The results are based on 5,695 responses to the cross-sectional
surveys of IDUs: 2,125 in Ning Ming; 2,677 in Lang Son; and
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1,060 in Ha Giang. Less than 5% of eligible respondents who were
approached refused to participate.
Coverage of the interventions among IDUs was generally 60%–
70% based on self-reported receipt of needles/syringes or
pharmacy vouchers in the cross-sectional surveys (data not shown).
This assumes that the survey samples were representative of the
total IDU population in the sites. Over the course of the project,
an average of 7,000–10,000 new needles/syringes were provided
per month in each site, taking into account both direct distribution
and redemption of pharmacy vouchers (Abt Associates Inc.,
unpublished data). The estimated numbers of IDUs were 1,700 in
Ning Ming, 1,700 in Lang Son and 1,000 in Ha Giang, so that the
program provided approximately 70 sterile syringes per IDU per
year.
Analysis of demographic characteristics (data not shown)
revealed that in all sites IDUs were predominantly males between
21 and 30 years old (although there was some tendency for the
samples to age over time), and about two-thirds were single. Ethnic
minorities (e.g., Nung or Tay in Vietnam; Zhuang, Dong, Miao,
Yao, or Jing in China) contributed substantial percentages to these
IDU samples: usually 70%–80% in Ning Ming, 45%–60% in
Lang Son, and 20%–40% in Ha Giang.
Table 1 shows self-reported drug-related risk behaviors among
IDUs. Regression-based linear time trends show that these
measures fell in all sites over the course of the interventions and
these reductions were generally significant.
Survey results regarding self-reported sexual risk behaviors (data
not shown) reveal no clear trends. However, they indicate that
from one-half to two-thirds of IDUs are sexually active and that
they report low rates of condom use with regular partners but
higher rates with casual or commercial partners. In most survey
waves, less than 20% of IDUs reported patronizing sex workers.
Table 2 and Figure 2 present the HIV prevalence trends,
showing statistically significant reductions in the Cross-Border
sites. While there were differences in the prevalence patterns
across the comparison provinces in Northern Vietnam, with
several increasing while others declined or were stable, the overall
estimated change was a reduction of 1.2% with a standard error of
2.44% in these comparison provinces, which is statistically
indistinguishable from no change (See Table S1 for details). In
Lang Son, by contrast, the estimated change in HIV prevalence
from 2004 to 2009 (i.e., from the 18- to 84-month surveys) was a
reduction of 12.1% with a standard error of 3.0%. In Ha Giang
(also from the 18- to 84-month surveys), the estimated change was
a reduction of 32.1% with a standard error of 5.0%. When
differencing out the underlying trend in other northern provinces,
the prevalence reductions in both Lang Son (11.0%, p = 0.002)
and Ha Giang (30.9%, p,0.001) from 2004 to 2009 are
statistically different from zero and thus significantly larger than
in the comparison provinces. In China, we estimated a 0.2% drop
in HIV prevalence in Yunnan with a standard error of 1.5%,
compared to a 4.4% drop in Ning Ming (i.e., from the 18–72
month surveys) with a standard error of 2.3% (see Table S2 for
details). The standard errors are White heteroskedastic-consistent
standard errors. The difference is statistically significant (4.1%,
p = 0.019).
Table 3 and Figure 3 reveal reduced HIV incidence by both
new injector and BED-based analysis. There are some apparent
incidence increases among new injectors in the more recent survey
waves, while the BED-based estimates reveal more consistently
low incidence in these later waves. As shown in Figure 3, the 95%
confidence intervals are substantially wider for the new injector-
based estimates than for the BED-based estimates. This is in part
due to the fact that there were far fewer new injectors in these later
waves.
To address potential problems with false-recent results in BED
testing, we applied the Welte adjustment [43] and examined
survey responses. Table 3 presents the BED-based incidence
estimates following application of the Welte adjustment, revealing
very similar trends in all sites. The unadjusted and adjusted BED-
based incidence trends are shown together in Figure 4.
Survey responses confirmed the BED-based estimates for all but
the Ha Giang 96-month survey. Of 41 BED-recent subjects from
all sites and all waves, four reported having been previously told
that they were HIV-infected. One individual who reported being
told of his HIV infection about seven months prior to the survey in
which his blood sample tested BED-recent was treated as a recent
infection. However, all three individuals with ‘‘recent’’ infections
based on BED testing of the 28 HIV-positive samples in the Ha
Giang 96-month survey were found to have been on ARV
treatment for 2–4 years. These determinations were based on
information from questionnaire responses, outpatient clinic patient
registries, and project peer educators. Thus, all three of these cases
were considered false recents on BED testing, thus producing a 0%
annual HIV incidence estimate for the Ha Giang 96-month
survey.
Discussion
The analysis of the Cross-Border Project data reveals consistent
reductions in drug-related HIV risk behaviors, HIV prevalence,
and HIV incidence among IDUs in the project sites in Northern
Vietnam and Southern China. Since this is neither a randomized
trial nor a quasi-experimental study but rather an ecological study
based on cross-sectional data, we cannot draw firm conclusions
that our interventions caused the positive trends we have observed.
However, this problem is reduced in that the Cross-Border Project
is implementing structural interventions, which are appropriately
evaluated using community cross-sectional data. In addition, the
consistency in trends across the primary outcomes strongly
supports a positive intervention effect.
The Cross-Border findings suggest that peer-based interventions
for IDUs that provide large numbers of needles/syringes by
multiple means (direct distribution, pharmacy vouchers, and
secondary exchange) without limits on numbers per contact can
control HIV epidemics among IDUs. There have been similar
findings from other places, for example, New York City where
reductions in HIV incidence among IDUs followed large-scale
implementation of peer outreach and needle/syringe programs
[46].
The successful use of current IDUs as peer educators is also a
noteworthy feature, as such PEs were demonstrated to have
efficient access to and trust among the target population. Coverage
of the Cross-Border interventions has been quite high (60%–70%
of IDUs) in all sites but some reductions in coverage were observed
in Ning Ming, China in the most recent cross-sectional surveys.
This, and concomitant reductions in the average monthly numbers
of needles/syringes provided, have probably resulted from reduced
levels of funding for the interventions in Ning Ming. However,
these changes have not yet occasioned any rebound in HIV
prevalence or incidence among IDUs. This suggests that the
interventions are truly structural in that they have changed
behavioral norms in the IDU community and thus no longer need
directly reach very high percentages of IDUs in order to maintain
low levels of HIV risk behavior and associated HIV transmission.
The success of such structural interventions depends greatly on
building and maintaining community support and collaboration
Cross-Border HIV Prevention in Vietnam and China
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with police and other officials. The importance of such support has
been noted in assessments of other needle/syringe programs in
Vietnam [15] and has been successfully maintained over the long
term by the Cross-Border Project [28].
There are several other issues and potential limitations
regarding the design of the study and the methods of collecting
and analyzing the primary outcome indicators that require
discussion. It is possible that our survey samples are not fully
representative of IDU populations in the sites. The use of
snowball sampling methods may introduce sampling bias and
dependence that may influence analytic results. However, we are
unable to explore or adjust for such influences because, in part to
protect participants’ confidentiality, we did not record which
participants came from which snowball strings. Nevertheless, in
studies of IDU populations, it is common practice to use targeted
or snowball samples because these are often the best methods
that are feasible. This point is supported in several extensive
literature reviews [25,47].
Self-reported behavioral data may be subject to biases. For
example, the very low reported rates of needle/syringe sharing in
the Vietnam sites from the very first survey waves may reflect
responses based on social desirability. In fact, this seems likely
given the high HIV incidence among new injectors in the early
survey waves.
High risk sexual behaviors remain prevalent among IDUs,
indicating a need to intensify interventions in this domain. Sexual
partners of IDUs may be at particular risk. Indeed, cross-sectional
surveys in this group, conducted to evaluate companion interven-
tions for women at risk, revealed HIV prevalence of 2%–5% in
Ning Ming and Ha Giang and a sharply higher 22% in Lang Son
(Abt Associates, unpublished data). Cross-sectional surveys of
sexual partners of IDUs in Hanoi reveal HIV prevalence between
9% and 14% [48].
In general, biological measures are more reliable than self-
reported behavioral data for assessing the effectiveness of
interventions. A strength of our evaluation is that we have
collected biological measures. The Cross-Border data reveal major
reductions in HIV prevalence among IDUs in Lang Son and Ha
Giang and more modest declines in Ning Ming. Declining
prevalence may reflect factors unrelated to intervention effects,
Table 1. Drug-related HIV risk behaviors.











Ning Ming County, China Baseline 290 47% 52% 41% 76%
6 month 331 29% 25% 22% 53%
12 month 303 22% 27% 18% 47%
18 month 299 17% 17% 13% 31%
24 month 209 9% 11% 8% 17%
36 month 210 7% 8% 6% 14%
48 month 238 14% 11% 6% 24%
72 month 245 10% 10% 3% 15%
p- value ,0.001 ,0.001 ,0.001 ,0.001
Lang Son Province, Vietnam Baseline 342 5% 6% 32% 47%
6 month 340 5% 5% 39% 47%
12 month 327 2% 1% 25% 46%
18 month 335 3% 4% 32% 41%
24 month 333 2% 1% 16% 30%
48 month 336 1% 1% 23% 26%
72 month 330 1% 2% 19% 25%
84 month 334 1% ,1% 10% 12%
p- value 0.004 ,0.001 ,0.001 ,0.001
Ha Giang Town, Vietnam Baseline1 100 23% 12% 56% 67%
6 month1 100 6% 4% 16% 17%
12 month1 98 14% 8% 39% 50%
18 month1 98 2% 0% 41% 44%
24 month 98 19% 20% 43% 59%
36 month 99 5% 9% 39% 44%
48 month 100 5% 3% 12% 16%
60 month 100 1% 0% 20% 20%
72 month 100 0% 0% 15% 16%
96-month 167 10% 8% 28% 35%
p- value 0.004 0.115 ,0.001 ,0.001
1During this period, a Peer-Driven Intervention was being implemented; by the 24-month survey, the intervention had been changed to a peer outreach model.
doi:10.1371/journal.pone.0043141.t001
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such as deaths or mobility in the target or surveyed population.
However, the declines in prevalence in our project sites are not
likely due to underlying trends, since other provinces of northern
Vietnam and in Yunnan Province, China, without such interven-
tions did not experience similar declines in prevalence. These
comparisons support the conclusion that the Cross-Border
Figure 2. HIV prevalence trend among IDUs.
doi:10.1371/journal.pone.0043141.g002
Table 2. HIV prevalence among IDUs: Cross-Sectional Surveys.
Ning Ming County, China Lang Son Province, Vietnam Ha Giang Town, Vietnam
Survey Wave n HIV Prevalence n HIV Prevalence n HIV Prevalence
Baseline 290 17% 342 46% 100 51%1
6 month 331 23% 340 46% 100 33%1
12 month 303 14% 327 43% 98 38%1
18 month 299 13% 335 37% 98 24%1
24 month 209 14% 333 32% 98 30%
36 month 210 14% NA 99 23%
48 month 238 11% 336 27% 100 17%
60 month NA NA 100 11%
72 month 245 11% 330 27% 100 15%
84 month NA 334 23% NA
96 month NA NA 167 18%
p-value 0.003 ,0.001 ,0.001
1During this period, a Peer-Driven Intervention was being implemented; by the 24-month survey, the intervention had been changed to a peer outreach model.
doi:10.1371/journal.pone.0043141.t002
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Figure 3. HIV Incidence Estimates by 2 Methods with 95% Confidence Intervals.
doi:10.1371/journal.pone.0043141.g003
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interventions have had a positive effect on declining HIV
prevalence among IDUs.
HIV incidence is the most important indicator of effectiveness
but few evaluations of HIV prevention interventions for IDUs
have examined incidence trends. The Cross-Border project
analysis reveals reduced HIV incidence in all sites although there
are some differences between the new injector and BED-based
incidence estimates. Incidence among new injectors declined
sharply in all sites in the survey waves following full implemen-
tation of the interventions [16] but there appear to be some
rebounds in later waves, especially in Ning Ming. We believe that
these later results may be unreliable, particularly given the much
lower incidence for these same waves based on BED testing. The
new injector estimation method relies on an assumption that a new
injector was HIV-negative at the time he initiated injection. While
this may have been a safe assumption for the early survey waves
when the HIV epidemic was growing sharply among IDUs, it may
not be reliable for the later waves when the epidemic had become
more mature and more sexual transmission had begun to occur. In
these later waves, it is possible that an individual could already
have been infected with HIV through sexual contact by the time
he initiated injection, which would distort the incidence estimate
upward. As a result, we are inclined to give more credence to the
BED-based incidence estimates, especially for the later survey
waves.
It is also important to recognize the possible problems with the
BED-based estimates. The BED assay can be non-specific,
particularly in African settings. False-recent BED test results can
occur in persons with long-term infection and those on ARV
treatment [49–55]. Such errors would tend to produce artificially
inflated incidence estimates. However, in a recent study of BED
performance in Thailand, where the epidemic is dominated by
similar viral subtypes as found in northern Vietnam and southern
China, very few false-recent cases were observed [34]. Application
of adjustments for false-recency in that study reduced the
incidence estimates to the conventional cohort-based observed
incidence, suggesting that false-recency may be less problematic in
Southeast Asia, or in the viral subtypes that predominate in this
region. While debate continues on the most appropriate adjust-
ment factor to apply for specific settings [56], we selected the
Welte adjustment [43], as recommended by CDC and the Office
of the Global AIDS Coordinator [57] and as used in the Thailand
study [34]. Moreover, in our surveys, participant-level data were
available allowing removal from analysis of cases that could
generate false-recent results on the BED assay.
In any event, overestimation is not a problem for BED-based
estimates in the later survey waves, which are already extremely
low, except for the Ha Giang 96-month survey in which the three
BED-based ‘‘recent’’ infections, if correctly identified, would have
resulted in a sharp incidence increase because of the small
numbers involved. As reported above, we found that these three
cases were all false-recents on the BED test, resulting in a 0%
annual incidence estimate for the Ha Giang 96-month survey.
Artificially high estimates in the earlier surveys could undermine
the validity of the observed downward incidence trend. However,
the BED and other assays to detect recent infections are ideally
suited to longitudinal surveys such as this where the objective is to
determine trends over time because assay-based biases that might
be present at one time would likely persist at others, making it very
likely that the downward trend observed in the BED-based
incidence is real even if some overestimation existed. Moreover,
the estimates from the new injector analysis, the survey responses
regarding individuals’ duration of infection, and trends observed
after the application of the Welte adjustment [43] all corroborate
the higher incidence rates in the earlier survey waves and thus
support the downward trend.
Combining the incidence trends from the new injector analysis
and the BED testing, we find sharp declines in HIV incidence
among IDUs in all sites. The only other study of IDUs in Vietnam
that has measured HIV incidence was in Thai Nguyen Province,
where an intervention without needle/syringe provision was being
implemented. HIV incidence in a cohort study conducted there
between 2005 and 2007 was 5% per year [58], higher than the
rates found in the later Cross-Border survey waves.
Despite the limitations of the study, we conclude that the Cross-
Border interventions have played an important role over an eight-
year period in controlling HIV transmission among IDUs and, as
a result, offer a model of HIV prevention for IDUs that should be
considered for large-scale replication.
Table 3. HIV Incidence Estimates by 3 Methods.














Baseline 0.12 0.06 0.03 0.22 NA NA 0.311 NA NA
6 month 0.20 0.10 0.07 0.22 NA NA 0.181 NA NA
12 month 0.09 0.04 0.02 0.16 NA NA 0.231 NA NA
18 month 0.07 0.01 20.01 0.12 NA NA 0.14 NA NA
24 month 0.08 0.01 20.01 0.08 NA NA 0.39 NA NA
36 month 0.00 0.03 0.01 NA NA NA 0.11 NA NA
48 month 0.06 0.01 20.008 0.03 0.00 0.00 0.00 NA NA
60 month NA NA NA NA NA NA 0.10 0.00 0.00
72 month 0.11 0.00 0.00 0.03 0.01 20.01 0.22 0.05 0.03
84 month NA NA NA 0.03 0.01 20.004 NA NA NA
96 month NA NA NA NA NA NA 0.02 0.00 20.04
1During this period, a Peer-Driven Intervention was being implemented; by the 24-month survey, the intervention had been changed to a peer outreach model.
doi:10.1371/journal.pone.0043141.t003
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Figure 4. Incidence Estimates with Welte Adjustment.
doi:10.1371/journal.pone.0043141.g004
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